GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)
Close on Nov 17, 2026Market cap $143.45MP/E –Yield –
GT Biopharma EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
GT Biopharma's EV/EBITDA was 537.5× on Jan 29, 2021.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jan 29, 2021 | 537.5× | +52.6 |
| 2020 | Dec 31, 2020 | 484.9× | – |
See a number that looks wrong?